61P: Response to first-line osimertinib plus pemetrexed/carboplatin in EGFR-mutant advanced NSLCLC with high PDL1 expression
Year: 2025
Type: article
Source: Journal of Thoracic Oncology
Authors: C. Weng, Y. Jiao, Q-Q. Tan, J. Liu, H-J. Chen, J-J. Yang
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4408979445
